Eli Lilly & Co. (LLY)
1078.73
+0.98
(+0.09%)
USD |
NYSE |
Dec 29, 16:00
1080.19
+1.46
(+0.14%)
Pre-Market: 05:54
Eli Lilly Research and Development Expense (Quarterly): 3.466B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Adverum Biotechnologies, Inc. | 38.91M |
| Viking Therapeutics, Inc. | 89.95M |
| Moderna, Inc. | 749.00M |